tiprankstipranks
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Similar Stocks

211 Followers

Other Large Cap Stocks Paying Dividends

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Y-Mabs Therapeutics
$547.22M
-25.14
73.92%
4 Buy
1 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$4.09B
-5.62
1.80%
17 Buy
1 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$4.92B
-21.27
-0.55%
9 Buy
6 Hold
1 Sell
Moderate Buy
AnaptysBio
$822.29M
-4.91
60.36%
5 Buy
2 Hold
0 Sell
Moderate Buy
Arvinas Holding Company
$1.98B
-4.87
17.36%
13 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
YMAB
Y-Mabs Therapeutics
12.47
5.24
72.48%
RARE
Ultragenyx Pharmaceutical
45.14
0.93
2.10%
CRSP
Crispr Therapeutics AG
57.90
0.15
0.26%
ANAB
AnaptysBio
30.10
10.72
55.31%
ARVN
Arvinas Holding Company
28.87
4.61
19.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis